-
1دورية أكاديمية
المؤلفون: van der Heijde, Désirée, Durez, Patrick, Schett, Georg, Naredo, Esperanza, Østergaard, Mikkel, Meszaros, Gabriella, De Leonardis, Francesco, de la Torre, Inmaculada, López-Romero, Pedro, Schlichting, Douglas, Nantz, Eric, Fleischmann, Roy
المساهمون: UCL - SSS/IREC/RUMA - Pôle de Pathologies rhumatismales, UCL - (SLuc) Service de rhumatologie
المصدر: Clinical Rheumatology, Vol. 37, no.9, p. 2381-2390 (2018)
مصطلحات موضوعية: Antirheumatic Agents, Arthritis, Rheumatoid, Azetidines, C-Reactive Protein, Disease Progression, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Methotrexate, Middle Aged, Odds Ratio, Sulfonamides, Treatment Outcome, Baricitinib, Joint damage, RA-BEGIN study, Rheumatoid arthritis, Structural progression
العلاقة: boreal:220481; http://hdl.handle.net/2078.1/220481Test; info:pmid/30078086; urn:ISSN:0770-3198; urn:EISSN:1434-9949
-
2دورية أكاديمية
المؤلفون: van der Heijde, Désirée, Durez, Patrick, Schett, Georg, Naredo, Esperanza, Østergaard, Mikkel, Meszaros, Gabriella, De Leonardis, Francesco, de la Torre, Inmaculada, López-Romero, Pedro, Schlichting, Douglas, Nantz, Eric, Fleischmann, Roy
المساهمون: UCL - SSS/IREC/RUMA - Pôle de Pathologies rhumatismales, UCL - (SLuc) Service de rhumatologie
المصدر: Clinical Rheumatology, Vol. 37, no.9, p. 2381-2390 (2018)
مصطلحات موضوعية: Antirheumatic Agents, Arthritis, Rheumatoid, Azetidines, C-Reactive Protein, Disease Progression, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Methotrexate, Middle Aged, Odds Ratio, Sulfonamides, Treatment Outcome, Baricitinib, Joint damage, RA-BEGIN study, Rheumatoid arthritis, Structural progression
العلاقة: boreal:220481; http://hdl.handle.net/2078.1/220481Test; info:pmid/30078086; urn:ISSN:0770-3198; urn:EISSN:1434-9949